Ticker
GERNCompany Name
GERON CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 79.6M | 1.24 | $ 64.28M |
3/31/2025 | $ 85.61M | 1.36 | $ 63.03M |
12/31/2024 | $ 80.88M | 0.92 | $ 88.3M |
9/30/2024 | $ 62.2M | 0.45 | $ 137.93M |
6/30/2024 | $ 118.07M | 1.14 | $ 103.54M |
3/31/2024 | $ 190.88M | 1.55 | $ 123.16M |
12/31/2023 | $ 71.14M | 0.66 | $ 108.07M |
9/30/2023 | $ 31.25M | 0.35 | $ 89.39M |
6/30/2023 | $ 57.44M | 0.79 | $ 72.57M |
3/31/2023 | $ 113.14M | 2.58 | $ 43.91M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for GERON CORP is calculated as follows: CashnEq [ $ 45.32M ] / LiabilitesC [ $ 24.15M ]
(=) Cash Ratio [ 1.88 ]
Minimum
Dec 31, 2020
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |